FDA to review whether to allow more access to certain peptides

medicalxpress - The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.

AI Summary: The FDA is moving toward expanding access to certain compounded peptides, opening a regulatory review that could loosen limits on how pharmacies and clinics obtain and prepare these popular therapies. The review balances potential patient demand and shortages against safety and quality-control concerns, putting compounding practices squarely under the spotlight.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #fda #supplychain

RevMed’s stunning success; FDA to reclassify peptides; and more

6 wks / endpoints / Nicole DeFeudis

Will retatrutide help me lose weight or look 'shredded?'

6 wks / medicalxpress

Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally

6 wks / beckershospitalreview / Elizabeth Casolo

FDA to review whether to allow more access to certain peptides

6 wks / medicalxpress

FDA moves toward easing restrictions on certain peptides

6 wks / healthcaredive / Kristin Jensen

FDA weighs support for compounding popular peptides

6 wks / endpoints / Max Bayer

StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Health Disparities, Pediatric Oncology, Infant Health, Research Funding and look for the RSS link.

StackHealth Time Machine

More StackHealth